These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 29684617)
1. Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population. Chen M; Luo Y; Yang S; Xu L; Li N; Li H; Qu S Diabetes Res Clin Pract; 2018 Jul; 141():80-87. PubMed ID: 29684617 [TBL] [Abstract][Full Text] [Related]
2. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men. Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033 [TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and HbA1c levels associated with high grade prostate cancer. Ozbek E; Otunctemur A; Dursun M; Sahin S; Besiroglu H; Koklu I; Erkoc M; Danis E; Bozkurt M Asian Pac J Cancer Prev; 2014; 15(6):2555-8. PubMed ID: 24761863 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score. Fang D; Ren D; Zhao C; Li X; Yu W; Wang R; Wang H; Xi C; He Q; Wang X; Xin Z; Zhou L Biomed Res Int; 2015; 2015():596797. PubMed ID: 26557679 [TBL] [Abstract][Full Text] [Related]
5. Phi-based risk calculators performed better in the prediction of prostate cancer in the Chinese population. Wu YS; Fu XJ; Na R; Ye DW; Qi J; Lin XL; Liu F; Gong J; Zhang N; Jiang GL; Jiang HW; Ding Q; Xu J; Sun YH Asian J Androl; 2019; 21(6):592-597. PubMed ID: 30924451 [TBL] [Abstract][Full Text] [Related]
6. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy. Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200 [TBL] [Abstract][Full Text] [Related]
7. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011. Na R; Jiang H; Kim ST; Wu Y; Tong S; Zhang L; Xu J; Sun Y; Ding Q PLoS One; 2012; 7(11):e49914. PubMed ID: 23189170 [TBL] [Abstract][Full Text] [Related]
9. Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population. Na R; Ye D; Liu F; Chen H; Qi J; Wu Y; Zhang G; Wang M; Wang W; Sun J; Yu G; Zhu Y; Ren S; Zheng SL; Jiang H; Sun Y; Ding Q; Xu J Prostate; 2014 Nov; 74(15):1569-75. PubMed ID: 25176131 [TBL] [Abstract][Full Text] [Related]
10. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048 [TBL] [Abstract][Full Text] [Related]
11. [Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population]. Zhu XD; Zheng A; Wang ZQ; Shao Q Zhonghua Nan Ke Xue; 2018 Feb; 24(2):142-146. PubMed ID: 30156074 [TBL] [Abstract][Full Text] [Related]
12. Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL). Chung JH; Yu J; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeon SS J Korean Med Sci; 2020 Oct; 35(41):e342. PubMed ID: 33107227 [TBL] [Abstract][Full Text] [Related]
13. The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL. Ng CF; Chiu PK; Lam NY; Lam HC; Lee KW; Hou SS Int Urol Nephrol; 2014 Apr; 46(4):711-7. PubMed ID: 24136184 [TBL] [Abstract][Full Text] [Related]
14. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884 [TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy. Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy. Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079 [TBL] [Abstract][Full Text] [Related]
17. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [TBL] [Abstract][Full Text] [Related]
18. Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs. Jiang H; Liu F; Wang Z; Na R; Zhang L; Wu Y; Zheng J; Lin X; Jiang D; Sun J; Zheng SL; Ding Q; Xu J Prostate; 2013 Nov; 73(15):1651-9. PubMed ID: 23868750 [TBL] [Abstract][Full Text] [Related]
19. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review. Leone A; Gershman B; Rotker K; Butler C; Fantasia J; Miller A; Afiadata A; Amin A; Zhou A; Jiang Z; Sebo T; Mega A; Schiff S; Pareek G; Golijanin D; Yates J; Karnes RJ; Renzulli J Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):68-71. PubMed ID: 26857145 [TBL] [Abstract][Full Text] [Related]
20. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients. Dell'Atti L J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]